Henan Lingrui Pharmaceutical Co Ltd (600285) — Financial Flexibility Index
Henan Lingrui Pharmaceutical Co Ltd (600285) has a Financial Flexibility Index of 0.06x as of September 2025. Free cash flow of CN¥145.72 Million (operating CF CN¥140.12 Million minus capex CN¥5.61 Million) represents 0% of total liabilities (CN¥2.47 Billion). Check 600285 strategic assets to equity ratio to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Henan Lingrui Pharmaceutical Co Ltd Financial Flexibility Index (1999–2025)
Historical Financial Flexibility Index trend for Henan Lingrui Pharmaceutical Co Ltd across 27 annual periods. See working capital to net assets of Henan Lingrui Pharmaceutical Co Ltd to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Henan Lingrui Pharmaceutical Co Ltd (1999–2025)
Year-by-year free cash flow to debt coverage for Henan Lingrui Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see 600285 market cap.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.28x | CN¥610.71 Million | CN¥553.88 Million | CN¥2.20 Billion | ▼ -45.7% |
| 2024 | 0.51x | CN¥990.97 Million | CN¥875.86 Million | CN¥1.94 Billion | ▲ +21.0% |
| 2023 | 0.42x | CN¥834.63 Million | CN¥813.43 Million | CN¥1.97 Billion | ▼ -12.4% |
| 2022 | 0.48x | CN¥861.90 Million | CN¥834.91 Million | CN¥1.79 Billion | ▼ -21.2% |
| 2021 | 0.61x | CN¥922.59 Million | CN¥845.69 Million | CN¥1.51 Billion | ▲ +33.1% |
| 2020 | 0.46x | CN¥522.35 Million | CN¥450.53 Million | CN¥1.14 Billion | ▼ -1.1% |
| 2019 | 0.46x | CN¥509.19 Million | CN¥450.15 Million | CN¥1.10 Billion | ▼ -3.3% |
| 2018 | 0.48x | CN¥488.39 Million | CN¥436.25 Million | CN¥1.02 Billion | ▲ +46.0% |
| 2017 | 0.33x | CN¥363.53 Million | CN¥105.97 Million | CN¥1.10 Billion | ▲ +1.8% |
| 2016 | 0.32x | CN¥281.31 Million | CN¥63.26 Million | CN¥869.35 Million | ▲ +32.2% |
| 2015 | 0.24x | CN¥241.05 Million | CN¥156.82 Million | CN¥984.58 Million | ▼ -1.2% |
| 2014 | 0.25x | CN¥226.42 Million | CN¥124.32 Million | CN¥913.70 Million | ▼ -44.1% |
| 2013 | 0.44x | CN¥294.15 Million | CN¥127.27 Million | CN¥663.24 Million | ▲ +128.5% |
| 2012 | 0.19x | CN¥115.96 Million | CN¥15.43 Million | CN¥597.36 Million | ▼ -2.6% |
| 2011 | 0.20x | CN¥104.39 Million | CN¥40.49 Million | CN¥524.02 Million | ▲ +169.7% |
| 2010 | 0.07x | CN¥36.14 Million | CN¥-3.95 Million | CN¥489.25 Million | ▼ -84.3% |
| 2009 | 0.47x | CN¥177.69 Million | CN¥132.61 Million | CN¥378.52 Million | ▲ +154.0% |
| 2008 | 0.18x | CN¥77.35 Million | CN¥43.72 Million | CN¥418.55 Million | ▲ +10.4% |
| 2007 | 0.17x | CN¥60.83 Million | CN¥15.99 Million | CN¥363.31 Million | ▲ +51.5% |
| 2006 | 0.11x | CN¥43.32 Million | CN¥26.76 Million | CN¥392.03 Million | ▼ -17.5% |
| 2005 | 0.13x | CN¥52.58 Million | CN¥33.43 Million | CN¥392.44 Million | ▼ -36.8% |
| 2004 | 0.21x | CN¥76.16 Million | CN¥35.51 Million | CN¥359.36 Million | ▼ -5.0% |
| 2003 | 0.22x | CN¥64.60 Million | CN¥23.79 Million | CN¥289.65 Million | ▼ -49.2% |
| 2002 | 0.44x | CN¥123.47 Million | CN¥69.41 Million | CN¥281.00 Million | ▲ +71.2% |
| 2001 | 0.26x | CN¥40.70 Million | CN¥3.41 Million | CN¥158.59 Million | ▼ -34.1% |
| 2000 | 0.39x | CN¥41.42 Million | CN¥3.66 Million | CN¥106.33 Million | ▲ +321.0% |
| 1999 | 0.09x | CN¥10.45 Million | CN¥4.81 Million | CN¥112.94 Million | — |